$6.43
1.61% day before yesterday
Nasdaq, May 30, 10:00 pm CET
ISIN
US45780L1044
Symbol
INGN

Inogen, Inc. Stock price

$6.43
-0.71 9.89% 1M
-3.69 36.45% 6M
-2.75 29.93% YTD
-1.69 20.78% 1Y
-19.49 75.20% 3Y
-32.13 83.33% 5Y
-31.52 83.07% 10Y
Nasdaq, Closing price Fri, May 30 2025
-0.11 1.61%
ISIN
US45780L1044
Symbol
INGN
Sector

Key metrics

Market capitalization $172.75m
Enterprise Value $53.86m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 0.16
P/S ratio (TTM) P/S ratio 0.51
P/B ratio (TTM) P/B ratio 0.87
Revenue growth (TTM) Revenue growth 5.74%
Revenue (TTM) Revenue $339.96m
EBIT (operating result TTM) EBIT $-30.92m
Free Cash Flow (TTM) Free Cash Flow $-21.13m
Cash position $118.89m
EPS (TTM) EPS $-1.09
P/E forward negative
P/S forward 0.49
EV/Sales forward 0.15
Short interest 4.14%
Show more

Is Inogen, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,782 stocks worldwide.

Inogen, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

3 Analysts have issued a Inogen, Inc. forecast:

2x Buy
67%
1x Sell
33%

Analyst Opinions

3 Analysts have issued a Inogen, Inc. forecast:

Buy
67%
Sell
33%

Financial data from Inogen, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
340 340
6% 6%
100%
- Direct Costs 183 183
4% 4%
54%
157 157
20% 20%
46%
- Selling and Administrative Expenses 169 169
5% 5%
50%
- Research and Development Expense 19 19
14% 14%
6%
-9.99 -9.99
80% 80%
-3%
- Depreciation and Amortization 21 21
8% 8%
6%
EBIT (Operating Income) EBIT -31 -31
56% 56%
-9%
Net Profit -27 -27
72% 72%
-8%

In millions USD.

Don't miss a Thing! We will send you all news about Inogen, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Inogen, Inc. Stock News

Neutral
Seeking Alpha
25 days ago
Inogen, Inc. (NASDAQ:INGN ) Q1 2025 Earnings Conference Call May 7, 2025 5:00 PM ET Company Participants Ryan Peterson - Investor Relations Kevin Smith - President and CEO Mike Bourque - CFO Conference Call Participants Colin Clark - Stifel Mike Matteson - Needham & Company Margaret Andrew - William Blair Operator Welcome to Inogen's First Quarter 2025 Earnings Conference Call. At this time, al...
Neutral
Business Wire
25 days ago
GOLETA, Calif.--(BUSINESS WIRE)---- $INGN #AirwayClearance--Inogen Announces First Quarter 2025 Financial Results.
Neutral
Business Wire
2 months ago
GOLETA, Calif.--(BUSINESS WIRE)---- $INGN #AirwayClearance--Inogen To Present at 24th Annual Needham Virtual Healthcare Conference.
More Inogen, Inc. News

Company Profile

Inogen, Inc . engages in the development, manufacture, and marketing of portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its products consists of Inogen One G4 system, Inogen One G3 system, Inogen One G2 system, and Inogen at Home. The company was founded by Alison Perry, Alison Bauerlein, Brenton Taylor and Byron Myers on November 27, 2001 and is headquartered in Goleta, CA.

Head office United States
CEO Kevin Smith
Employees 766
Founded 2001
Website www.inogen.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today